Liraglutide: clinical pharmacology and considerations for therapy.

Sisson, Evan M·Pharmacotherapy·2011·
RPEP-018612011RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Liraglutide: clinical pharmacology and considerations for therapy.
Published In:
Pharmacotherapy, 31(9), 896-911 (2011)
Database ID:
RPEP-01861

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01861·https://rethinkpeptides.com/research/RPEP-01861

APA

Sisson, Evan M. (2011). Liraglutide: clinical pharmacology and considerations for therapy.. Pharmacotherapy, 31(9), 896-911. https://doi.org/10.1592/phco.31.9.896

MLA

Sisson, Evan M. "Liraglutide: clinical pharmacology and considerations for therapy.." Pharmacotherapy, 2011. https://doi.org/10.1592/phco.31.9.896

RethinkPeptides

RethinkPeptides Research Database. "Liraglutide: clinical pharmacology and considerations for th..." RPEP-01861. Retrieved from https://rethinkpeptides.com/research/sisson-2011-liraglutide-clinical-pharmacology-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.